Cite
MLA Citation
Pavel Klener et al.. “Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation.” American journal of hematology, vol. 94, no. 2, n.d., pp. E50–E53. http://access.bl.uk/ark:/81055/vdc_100076780841.0x000045